Excess weight is not only a risk factor for diabetes but also contributes to its progression and associated complications
However, semaglutide costs less ($199 compounded vs $349 for tirzepatide) and still provides excellent weight loss
Trial participation is not the same as receiving a routine prescription
SW and JY contributed to verify the data analysis
Experience improved gastrointestinal comfort and quality of life
The awardees are Daniel Drucker, an endocrinologist at the University of Toronto, Joel Habener, an endocrinologist at Harvard Medical School, Jens Juul Holst, a physiologist at the University of Copenhagen, Lotte Bjerre Knudsen, a pharmaceutical scientist at Novo Nordisk, and Svetlana Mojsov, a chemist at The Rockefeller University